Abbott Laboratories buy Daiwa Capital Markets
Start price
21.10.25
/
50%
€110.72
Target price
21.10.26
€116.80
Performance (%)
-4.61%
Price
23.12.25
€105.62
Summary
This prediction is currently active. With a performance of -4.61%, the BUY prediction by Daiwa_Capital_Market is trending in the wrong direction. This prediction currently runs until 21.10.26. The prediction end date can be changed by Daiwa_Capital_Market at any time. Daiwa_Capital_Market has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -2.149% | -2.149% |
| iShares Core DAX® | 1.732% | 4.638% |
| iShares Nasdaq 100 | 3.304% | 0.517% |
| iShares Nikkei 225® | 2.342% | 0.972% |
| iShares S&P 500 | 2.357% | 0.872% |
Comments by Daiwa_Capital_Market for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target raised by analysts at Daiwa Capital Markets from $134.00 to $136.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat